References
- Ferrier DR. Biochemistry. Harvey RA, editor. Philadelphia, PA: Lippincott Williams & Wilkins; 2014. p. 707–11.
- Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA. Vitamin D enhances corneal epithelial barrier function. Invest Ophthalmol Vis Sci. 2011;52:7359–64. doi:10.1167/iovs.11-7605.
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. doi:10.1056/NEJMra070553.
- Straube S, Derry S, Straube C, Moore RA. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev. 2015;5:CD007771.
- Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2010;118:142–50. doi:10.1016/j.jsbmb.2009.11.004.
- Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One. 2015;10(11):e0141770. doi:10.1371/journal.pone.0141770.
- Balvers MG, Brouwer-Brolsma EM, Endenburg S, de Groot LC, Kok FJ, Gunnewiek JK. Recommended intakes of vitamin D to optimise health, associated circulating 25-hydroxyvitamin D concentrations, and dosing regimens to treat deficiency: workshop report and overview of current literature. J Nutr Sci. 2015;4:23. doi:10.1017/jns.2015.10.
- Cashman KD, Kiely M. Towards prevention of vitamin D deficiency and beyond: knowledge gaps and research needs in vitamin D nutrition and public health. Br J Nutr. 2011;106:1617–27. doi:10.1017/S0007114511004995.
- Reins RY, McDermott AM, Vitamin D. Implications for ocular disease and therapeutic potential. Exp Eye Res. 2015;134:101–10. doi:10.1016/j.exer.2015.02.019.
- Karatepe AS, Köse S, Eğrilmez S. Factors affecting contrast sensitivity in healthy individuals: a pilot study. Turk J Ophthalmol. 2017;47:80–84. doi:10.4274/tjo.93763.
- Miller D, Schor P, Magnante P. Optics of the normal eye. In: Yanoff M, Duker J, editors. Ophthalmology. Mosby Elsevier; 2014. p. 43–44.
- Wood JM, Owens DA. Standard measures of visual acuity do not predict drivers’ recognition performance under day or night conditions. Optom Vis Sci. 2005;82:698–705. doi:10.1097/01.opx.0000175562.27101.51.
- Loshin DS, White J. Contrast sensitivity. The visual rehabilitation of the patient with macular degeneration. Arch Ophthalmol. 1984;102:1303–06. doi:10.1001/archopht.1984.01040031053022.
- Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1988;95:693–98. doi:10.1016/S0161-6420(88)33125-8.
- Marmor MF. Contrast sensitivity versus visual acuity in retinal disease. Br J Ophthalmol. 1986;70:553–59. doi:10.1136/bjo.70.7.553.
- Ridder A, Muller ML, Kotagal V, Frey KA, Albin RL, Bohnen NI. Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord. 2017;34:15–19. doi:10.1016/j.parkreldis.2016.10.006.
- Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000;35:1226–37. doi:10.1016/S0272-6386(00)70064-3.
- Alahmadi BO, Omari AA, Abalem MF, Andrews C, Schlegel D, Branham KH, Khan NW, Fahim A, Jayasundera T. Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations. BMC Ophthalmol. 2018;18:313. doi:10.1186/s12886-018-0982-0.
- Puell MC, Palomo-Alvarez C, Perez-Carrasco MJ. Macular inner retinal layer thickness in relation to photopic and mesopic contrast sensitivity in healthy young and older subjects. Invest Ophthalmol Vis Sci. 2018;59:5487–93. doi:10.1167/iovs.18-25334.
- Weale RA. Aging and vision. Vision Res. 1986;26:1507–12. doi:10.1016/0042-6989(86)90170-7.
- Eğrilmez S. Contrast sensitivity function. Optical refraction rehabilitation basic information. Turk Ophthalmol Soc. 2010;1:193–203.
- French AN, Ashby RS, Morgan IG, Rose KA. Time outdoors and the prevention of myopia. Exp Eye Res. 2013;114:58–68. doi:10.1016/j.exer.2013.04.018.
- Guggenheim JA, Northstone K, McMahon G, Ness AR, Deere K, Mattocks C, Pourcain BS, Williams C. Time outdoors and physical activity as predictors of incident myopia in childhood: a prospective cohort study. Invest Ophthalmol Vis Sci. 2012;53:2856–65. doi:10.1167/iovs.11-9091.
- Dulhunty AF, Beard NA, Pouliquin P, Kimura T. Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies. J Muscle Res Cell Motil. 2006;27:351–65. doi:10.1007/s10974-006-9086-1.
- Alsalem JA, Patel D, Susarla R, Coca-Prados M, Bland R, Walker EA, Rauz S, Wallace GR. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci. 2014;55:2140–47. doi:10.1167/iovs.13-13019.
- Wang H, Hartnett ME. Regulation of signaling events involved in the pathophysiology of neovascular AMD. Mol Vis. 2016;22:189–202.
- Parmeggiani F, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D’Angelo S, Perri P, De Palma P, De Nadai K, Sebastiani A. Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm. 2012;2012:546786. doi:10.1155/2012/546786.
- Lee V, Rekhi E, Hoh Kam J, Jeffery G. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging. 2012;33:2382–89. doi:10.1016/j.neurobiolaging.2011.12.002.
- Graffe A, Beauchet O, Fantino B, Milea D, Annweiler C. Vitamin D and macular thickness in the elderly: an optical coherence tomography study. Invest Ophthalmol Vis Sci. 2014;55:5298–303. doi:10.1167/iovs.14-13918.
- Singh A, Falk MK, Subhi Y, Sorensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One. 2013;8:e70948. doi:10.1371/journal.pone.0070948.
- Wang Y, Chiang YH, Su TP, Hayashi T, Morales M, Hoffer BJ, Lin SZ. Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology. 2000;39:873–80. doi:10.1016/S0028-3908(99)00255-5.
- Annweiler C, Beauchet O, Bartha R, Graffe A, Milea D, Montero-Odasso M. Association between serum 25-hydroxyvitamin D concentration and optic chiasm volume. J Am Geriatr Soc. 2013;61:1026–28. doi:10.1111/jgs.12249.
- Gungor A, Ates O, Bilen H, Kocer I. Retinal nerve fiber layer thickness in early-stage diabetic retinopathy with vitamin D deficiency. Invest Ophthalmol Vis Sci. 2015;56:6433–37. doi:10.1167/iovs.15-16872.
- Fjeldstad C, Fjeldstad AS, Weir JP, Pardo G. Association of vitamin D deficiency with RNFL thickness in MS individuals without history of optic neuritis. Mult Scler Relat Disord. 2014;3:489–93. doi:10.1016/j.msard.2014.03.001.